Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Expects Repo Rate to Hit Decade Low Milburn Welfare Spending Outpaces Youth Job Investment Calls for Reform HS2 Cost Estimates Surge to 1027bn Service Start Delayed Until 2039 Transport Secretary Says College Degree No Longer Guarantees Prosperity for Gen Z Survey Data Suggests The Mandalorian and Grogu Opens to 82 Million Marking Disneys Lowest Star Wars Debut MegaIPOs from SpaceX and OpenAI May Test Market Peak Analysts Caution ONB Q1 2026 Earnings Slight EPS Miss but Stock Holds Steady Nano Nuclear Energy Inc NNE Q1 2026 Earnings NarrowerThanExpected Loss Drives 347 EPS Surprise Stock Slips 59 OPHC Q1 2026 Earnings Earnings Per Share Falls Short of Consensus Shares Rise Modestly Worthington Enterprises Inc WOR Q1 2026 Earnings EPS Slightly Beats Estimates Amid Steady Operations NFE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises 575 AXP Q1 2026 Earnings EPS Beat of 533 Highlights Resilient Spending Lifetime Brands LCUT Shares Dip as Support Level Approaches Key Levels to Watch MSC Industrial Direct MSM Holds Steady Amidst Cautious Trading MFS Multimarket Income Trust MMT Holds Steady at 449 as Trading Range Narrows First Community Bankshares FCBC Holds Steady Near 42 Level Amid Sector Caution Edwards Lifesciences EW Slips 126 Amid Sector Headwinds Testing Key Support Levels Amazon Reports Record Sales During Thanksgiving Holiday Week CSX Q1 2026 Earnings EPS Beats Estimates by 925 as Stock Slips Prelude Therapeutics PRLD Slides 422 as Stock Approaches Key Support Level ING Q1 2026 Earnings EPS Beats Estimates by 66 as Provisions Remain Contained CIFR Q1 2026 Earnings Loss per Share Widens Misses Analyst Estimates NextCure Inc NXTC Q1 2026 Earnings EPS Beat Amid No Revenue and Steep Stock Decline Cheesecake Factory CAKE Q1 2026 Earnings EPS Beat Driven by Operational Strength Stock Edges Higher SKYX Q1 2026 Earnings EPS Falls Short of Estimates Amid Ongoing Development PTGX Q1 2026 Earnings Surprise Profit as Pipeline Advances Stock Edges Lower Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues